Skip to content

Clinical study and application of cGP in type 2 diabetes

Clinical study and application of cGP in type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078415
Enrollment
Unknown
Registered
2023-12-07
Start date
2021-02-25
Completion date
Unknown
Last updated
2023-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

T2DM:cGP
Health Group:none

Sponsors

Tianyou Hospital, affiliated with Wuhan University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: a. Diabetic patients who meet the World Health Organization (WHIO) 1999 diagnostic criteria for type 2 diabetes. b. Age 18-70 years; c. Good compliance; d. If other drugs are taken orally at the same time, it is recommended that the medication be maintained stable and not changed arbitrarily during the clinical period; e. Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: a. For autoimmune diseases: b. Severe infection, surgery, trauma, malnutrition: c. Abnormal thyroid function: d. Ketoacidosis DKA or hyperosmolar non-ketotic comas with acute complications of type 2 diabetes mellitus; e. People with cognitive disabilities: g. Pregnant and lactating persons.

Design outcomes

Primary

MeasureTime frame
HbA1c;Renal Function;Fundus photography;cGP;IGF-1;IGFBP-3;Blood glucose;Blood lipids;

Secondary

MeasureTime frame
Blood pressure;Complications;

Countries

China

Contacts

Public ContactYang Yang

Tianyou Hospital, affiliated with Wuhan University of Science and Technology

13554623321@126.com+86 135 5462 3321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026